Drug maker Granules India on Friday said it has received approval from the US health regulator to market a generic medication ...

Granules India has received USFDA approval to market a generic medication for major depressive disorder, Bupropion ...

Granules Pharmaceuticals, Inc., a 100% foreign subsidiary of Granules India received the U.S. Food & Drug Administration (USFDA) approval for abbreviated new drug application (ANDA) of Bupropion ...

Granules India announced today that the U.S. Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) for Bupropion Hydrochloride Extended-Release Tablets USP (SR) ...

COUNCIL chiefs have upheld a decision to re-locate Ulverston’s library service despite a consultation being labelled ‘not fair’ ...

The global fight against cancer is intensifying, and with it, the demand for innovative treatments is soaring. One of the ...

The FDA accepts and grants priority review to GSK's NDA for gepotidacin for treating uncomplicated urinary tract infections. A decision is due on March 26, 2025.

Researchers from the Center for Regenerative Medicine (CReM) at Boston University and Boston Medical Center (BMC) have ...

GSK PLC GSK shares inched up 0.03% to £14.97 Thursday, on what proved to be an all-around favorable trading session for the ...

DIA's Canada Annual Meeting, featuring regulatory, clinical, and safety and pharmacovigilance discussions, will be held Nov.

Wave Life Sciences reports that it has successfully carried out RNA editing in two patients with alpha-1 antitrypsin ...

In 2022, the global monoclonal antibodies market size was valued at USD 186 billion in 2021. The market is projected to ...